Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.52 USD
Change Today -0.17 / -2.54%
Volume 141.8K
CO On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:04 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

china cord blood corp (CO) Snapshot

Open
$6.61
Previous Close
$6.69
Day High
$6.69
Day Low
$6.52
52 Week High
08/17/15 - $7.69
52 Week Low
12/15/14 - $4.10
Market Cap
522.1M
Average Volume 10 Days
247.2K
EPS TTM
$0.20
Shares Outstanding
80.1M
EX-Date
--
P/E TM
32.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA CORD BLOOD CORP (CO)

china cord blood corp (CO) Related Businessweek News

No Related Businessweek News Found

china cord blood corp (CO) Details

China Cord Blood Corporation, together with its subsidiaries, primarily provides umbilical cord blood storage and ancillary services in the People’s Republic of China. The company provides cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as offers matching services. As of March 31, 2015, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company has a strategic collaboration with Cord Blood Registry to share data on cord blood collection, processing, and storage. China Cord Blood Corporation is based in Central, Hong Kong.

1,039 Employees
Last Reported Date: 07/31/15

china cord blood corp (CO) Top Compensated Officers

Chief Executive Officer, Director and Member ...
Total Annual Compensation: $345.8K
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $345.8K
Chief Executive Officer of Guangdong Division...
Total Annual Compensation: $259.6K
Chief Executive Officer of Beijing Division
Total Annual Compensation: $140.6K
Chief Technology Officer
Total Annual Compensation: $135.8K
Compensation as of Fiscal Year 2015.

china cord blood corp (CO) Key Developments

Nanjing Xinjiekou Likely To Win Bid For China Cord Blood

Nanjing Xinjiekou Department Store Co., Ltd. (SHSE:600682) is having increasing odds to win the bid on China Cord Blood Corporation (NYSE:CO) among a number of candidates. On August 26, 2015, five listed companies involved in the bid filed announcements respectively, together giving a clear picture of the takeover fight which is heading into the homestretch. Zhongyuan Union Cell & Gene Engineering Corp., Ltd had announced its plan to acquire a minority equity interest of China Cord. On August 26, 2015, Nanjing Xinjiekou published an announcement which said that it was in talks with China Cord's major shareholder Golden Meditech Holdings Limited (SEHK:801) about the acquisition of China Cord's assets and equity interests.

China Cord Blood Corporation Reports Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2015

China Cord Blood Corporation reported unaudited consolidated earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported revenues of RMB 165.363 million compared to RMB 153.331 million a year ago. Operating income was RMB 48.427 million compared to RMB 60.167 million a year ago. Income before income tax was RMB 28.482 million compared to RMB 41.531 million a year ago. Net income was RMB 13.493 million compared to RMB 29.594 million a year ago. Net income attributable to the company’s shareholders was RMB 13.551 million compared to RMB 29.736 million a year ago. Basic and diluted earnings per share was RMB 0.19 compared to RMB 0.37 a year ago. Non-GAAP operating income was RMB 74.848 million compared to RMB 71.574 million a year ago. Net cash provided by operating activities for the first quarter of fiscal 2016 was RMB 130.1 million compared to RMB 21.0 million a year ago.

China Cord Blood Corporation to Report Q1, 2016 Results on Aug 19, 2015

China Cord Blood Corporation announced that they will report Q1, 2016 results After-Market on Aug 19, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CO:US $6.52 USD -0.17

CO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CO.
View Industry Companies
 

Industry Analysis

CO

Industry Average

Valuation CO Industry Range
Price/Earnings 35.6x
Price/Sales 4.7x
Price/Book 1.9x
Price/Cash Flow 36.5x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA CORD BLOOD CORP, please visit www.chinacordbloodcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.